Advancing Supply Chain Resilience in Europe’s O...

By HEOR Staff Writer

April 28, 2026

In an interview with Adrian van den Hoven, Director General of Medicines for Europe, meaningful progress made in 2025 is highlighted, ...
Regulatory Divergence in PSMA Targeted Therapy: Implications for European Mar...
Advancing Multicenter AKI Prediction: Benefits of Collaborative Models Over L...
Economic Impact of Fragmented Care: Tackling Obesity, Diabetes, and Cardiovas...
HIV Prevention Partnerships: Expanding Access to Lenacapavir for Global Impact
Advancing Inclusive Healthcare Strategies Through Social Impact and Sustainab...
Utah’s AI Medication Prescribing Risks: Navigating the Challenges of Au...
Advancements in Pulsed Field Ablation: The VARIPULSE Pro Platform Launch
Expansion of Community Health Programs by Novartis to Tackle Global Health Di...
Antimicrobial Resistance Art: Bridging Science and Health Through Visual Stor...
100% Tariffs Impacting Pharmaceutical Manufacturing and National Security
Advancing Collaborative TB Innovation to Tackle Drug Resistance
Milestone Approval of Invasive Brain-Computer Interface Revolutionizes Spinal...